TRANSCRIPTION FACTOR BOB1 IS ESSENTIAL FOR GERMINAL CENTER-DERIVED B CELL MALIGNANCIES OFFERING AN ATTRACTIVE TARGET FOR TCR-BASED THERAPY

EHA Library, Rogier Reijmers, 266823

DEVELOPING A CRISPR-CAS9 TOOL TO INACTIVATE THE GLUCOCORTICOID RECEPTOR AND BROADEN THE APPLICABILITY OF ANTIGEN-SPECIFIC T-CELL IMMUNOTHERAPY

EHA Library, Chrysa Pantazi, 266824

EFFECTS OF NKTR-255, A POLYMER CONJUGATED HUMAN IL-15, ON EFFICACY OF CD19 CAR T CELL IMMUNOTHERAPY IN A PRECLINICAL LYMPHOMA MODEL.

EHA Library, Cassie Chou, 266825

NKG2D AND BCMA-CAR NK CELLS EFFICIENTLY ELIMINATE MULTIPLE MYELOMA CELLS. A COMPREHENSIVE COMPARISON BETWEEN TWO CLINICALLY RELEVANT CARS.

EHA Library, Elena Maroto Martín, 266826

DEVELOPMENT OF A NEXT GENERATION ALLOGENEIC CAR-T CELL PLATFORM WITHOUT GENE EDITING

EHA Library, Peggy Sotiropoulou, 266827

CD22 CAR T-CELL THERAPY IN 34 REFRACTORY OR RELAPSED B ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Jing Pan, 266828

UPDATED RESULTS FROM PHASE I TRIALS ASSESSING A NKG2D CAR T-CELL APPROACH IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME PATIENTS

EHA Library, David Sallman, 266829

SEQUENTIAL CD19- AND CD22-DIRECTED CAR-T CELL THERAPIES IN 11 REFRACTORY OR RELAPSED B-ALL CHILDREN PATIENTS

EHA Library, Jing Pan, 266830

INFECTIOUS COMPLICATIONS FOLLOWING ARI-0001 CELL (A3B1:CD8:4-1BB:CD3Z CART19) TREATMENT IN ADULT AND PEDIATRIC PATIENTS WITH CD19+ RELAPSED / REFRACTORY MALIGNANCIES

EHA Library, Valentín Ortiz-Maldonado, 266831

SAFETY AND TOLERABILITY OF ALLOGENEIC, OFF-THE SHELF PLACENTAL NATURAL KILLER CELLS (PNK 007) IN PHASE 1 MULTIPLE MYELOMA AND ACUTE MYELOID LEUKEMIA STUDIES (NCT02955550 AND NCT02781467)

EHA Library, Sharmila Koppisetti, 266832

CAR T-CELL THERAPY FOR LYMPHOMAS IN ITALY: THE ISTITUTO NAZIONALE DEI TUMORI OBSERVATIONAL STUDY AFTER THE EMA APPROVAL

EHA Library, GIULIA PERRONE, 266833

INTRA-BONE DLI AT RELAPSE AFTER ALLO-HSCT IMPROVES SURVIVAL WITH LOWERING OF PD-1 POSITIVITY OF CD8+ CELLS AND PRESERVATION OF THE PROFILE OF TCR BETA DOMINANT CLONES IN THE MARROW

EHA Library, Andrzej Lange, 266834

AUTOLOGOUS DENDRITIC CELL VACCINATION TO PREVENT PROGRESSION AND RELAPSE IN MULTIPLE MYELOMA

EHA Library, Ann VAN DE VELDE, 266835

CAUSES OF NON - ELIGIBILITY FOR CD19 CAR T-CELL IMMUNOTHERAPY IN PATIENTS WITH RELAPSE/REFRACTORY DLBCL. EXPERIENCE OF SAINT-LOUIS HOSPITAL

EHA Library, Jérôme PAILLASSA, 266836

EX-VIVO HEMATOPOIETIC STEM CELL GENE THERAPY (GT) FOR MUCOPOLYSACCHARIDOSIS TYPE I HURLER (MPSIH): PRELIMINARY RESULTS FROM A PHASE I/II CLINICAL STUDY

EHA Library, Maria Ester Bernardo, 266837

LONG-TERM EFFICACY AND SAFETY OF INOTERSEN FOR HEREDITARY TRANSTHYRETIN AMYLOIDOSIS: NEURO-TTR OPEN-LABEL EXTENSION 2-YEAR UPDATE

EHA Library, Spencer Guthrie, 266838

IL-6 ASSOCIATED WITH GRADING OF CYTOKINE RELEASE SYNDROME AND MANAGEMENT TIME OF TOCILIZUMAB AFTER CAR-T CELL THERAPY

EHA Library, Heng Mei, 266839

INTERIM ANALYSIS OF A WT-1 AND PRAME ‘FAST-DC’ VACCINE SHOWS SAFETY AS ACTIVE IMMMUNOTHERAPY FOR THE PREVENTION OF AML RELAPSE

EHA Library, Yngvar Fløisand, 266840

DOWNREGULATION OF ENDOTHELIAL GENE MYCT1 IN HUMAN HSCS DURING EX VIVO CULTURE COMPROMISES THEIR FUNCTION

EHA Library, Júlia Aguadé-Gorgorió, 266841

NOVEL PRO-INFLAMMATORY MACROPHAGES ARE INVOLVED IN HEMATOPOIETIC STEM CELL DEVELOPMENT

EHA Library, Elaine Dzierzak, 266842

DEVELOPMENT OF INNOVATIVE PRECLINICAL IN VITRO AND IN VIVO TOOLS FOR AN EFFECTIVE THERAPEUTIC STRATEGY IN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Giulia Borella, 266843

SF3B1 KNOCKDOWN AT EARLY ERYTHROPOIESIS INDUCED CELL APOPTOSIS BY USING A TET-ON LENTIVIRAL VECTOR

EHA Library, Yumin Huang, 266845

CHARACTERIZING THE ETIOLOGY OF PEDIATRIC ACUTE MYELOID LEUKEMIA BY STUDYING MUTATION ACCUMULATION IN NORMAL HEMATOPOIESIS

EHA Library, Arianne Brandsma, 266846

DEFINING THE ROLE OF E-CADHERIN DURING HEALTHY AND MALIGNANT HEMATOPOIESIS

EHA Library, Rosa Krimpenfort, 266847

ACTIVATION OF AUTOPHAGY IN ENDOTHELIAL CELLS ENHANCES HEMATOPOIETIC STEM CELLS

EHA Library, Xie-Na Cao, 266848

RAPID MAST CELL GENERATION FROM GATA2 REPORTER HUMAN PLURIPOTENT STEM CELLS

EHA Library, Carmen Rodriguez Seoane, 266849

HES1 AND HES4 HAVE SIMILAR AND DIVERSE CAPACITIES TO MEDIATE HUMAN NOTCH-DEPENDENT HEMATOPOIETIC LINEAGE DECISIONS.

EHA Library, Matthias De Decker, 266850

APPLICATION OF FLOW SOM TO CLASSICAL FLOW CYTOMETRY : UNSUPERVISED ANALYSIS OF HEMATOPOIESIS AND HEMATOLOGICAL MALIGNANCIES.

EHA Library, Marie Christine Béné, 266851

RED BLOOD CELL GENERATION FROM HUMAN INDUCED PLURIPOTENT STEM CELLS

EHA Library, Emile van den Akker, 266852

COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS OF MULTIPLE TREATMENT STRATEGIES USING ABVD AND/OR BEACOPP IN THE TREATMENT OF ADVANCED-STAGE HODGKIN LYMPHOMA

EHA Library, Abi Vijenthira, 266853

DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVOURABLE HODGKIN LYMPHOMA (CHL): RESULTS OF A PHASE II, PROSPECTIVE, MULTI‐CENTER STUDY BY FONDAZIONE ITALIANA LINFOMI

EHA Library, Rita Mazza, 266854

AUTOLOGOUS T CELLS MODIFIED BY CD30 & CD22 DUAL SPECIFIC CAR COMBINED SECRETION OF ANTI-PDL1 SCFV IN TREATING PATIENTS WITH RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

EHA Library, Jianqiang Li, 266855

NIVOLUMAB FOR TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN’S LYMPHOMA (CHL): CLINICAL AND PATIENT-REPORTED OUTCOMES

EHA Library, Lepik Kirill, 266856

EVEROLIMUS WITH DHAP (DEXAMETHASONE, HIGH-DOSE ARAC, CISPLATINUM) IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RANDOMIZED, PLACEBO-CONTROLLED PHASE I/II TRIAL (HD-R3I)

EHA Library, Bastian Von Tresckow, 266857

CHECKPOINT INHIBITOR TREATMENT BEFORE HAPLOIDENTICAL TRANSPLATATION IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA (HL) PATIENTS IS ASSOCIATED WITH HIGHER PFS WITHOUT INCREASED TOXICITIES.

EHA Library, Luca Castagna, 266858

RETREATMENT WITH NIVOLUMAB IN PATIENTS WITH R/R CLASSICAL HODGKIN LYMPHOMA AFTER DISCONTINUATION OF THE THERAPY WITH IMMUNE CHECKPOINT INHIBITORS

EHA Library, Liudmila Fedorova, 266859

JAK-INHIBITION WITH RUXOLITINIB IN PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A PHASE II, OPEN LABEL, MULTICENTER CLINICAL TRIAL (JERICHO)

EHA Library, Bastian Von Tresckow, 266860

REAL-WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) OF PATIENTS DIAGNOSED WITH CLASSICAL HODGKIN LYMPHOMA (CHL) TREATED WITH ANTI-PD1 CHECKPOINT INHIBITORS IN THE UNITED STATES (US)

EHA Library, Monika Raut, 266861

NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI-CENTER EXPERIENCE IN TURKEY

EHA Library, Burhan Ferhanoglu, 266862

GRAFT SOURCE AND PRE-TRANSPLANT DISEASE STATUS ARE THE MAIN VARIABLES AFFECTING THE OUTCOME OF T CELL-REPLETE HAPLOIDENTICAL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR HODGKIN LYMPHOMA

EHA Library, Jacopo Mariotti, 266863

EZH2 GAIN-OF-FUNCTION MUTATIONS ARE NOT ASSOCIATED WITH MORE FAVORABLE PROGNOSIS IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A PRELIMINARY ANALYSIS ON 590 PATIENTS

EHA Library, Jessica Okosun, 266864

COMPREHENSIVE ANALYSIS OF BASELINE OUTCOME BIOPREDICTORS IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: THE ANCILLARY BIOLOGICAL STUDIES OF FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 CLINICAL TRIAL

EHA Library, Simone Ferrero, 266865

EXTRANODAL AND SPLEEN DISEASE DETECTED BY FDG-PET/CT IS ASSOCIATED WITH EARLY CLINICAL FAILURE IN UNTREATED FOLLICULAR LYMPHOMA

EHA Library, Frederique St-Pierre, 266866

PRIMARY THERAPY AND SURVIVAL OF FOLLICULAR LYMPHOMA IN THE NETHERLANDS: A POPULATION-BASED ANALYSIS AMONG 12,008 PATIENTS DIAGNOSED FROM 1989 TO 2016

EHA Library, Manette Dinnessen, 266867

CLINICO-BIOLOGICAL CHARACTERISTICS AND TREATMENT OUTCOMES FOR BLASTOID MANTLE CELL LYMPHOMA PATIENTS INCLUDED IN CLINICAL TRIALS. A LYSA STUDY.

EHA Library, Mathieu BALDACINI, 266868

PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R2) THAN RITUXIMAB/PLACEBO (AUGMENT)

EHA Library, John Gribben, 266869

MAGNIFY: PHASE IIIB INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA

EHA Library, Mathias J. Rummel, 266870

CHARACTERISTICS AND OUTCOME OF PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA AFTER RETREATMENT WITH SECOND-LINE RITUXIMAB-CONTAINING CHEMOTHERAPY

EHA Library, Jiajia Liu, 266871

EFFICACY OF R-BAC IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA POST BTK INHIBITOR THERAPY

EHA Library, Rory McCulloch, 266872

CONTEMPORARY TREATMENT PATTERNS AND RESPONSE IN RELAPSE/REFRACTORY CUTANEOUS T-CELL LYMPHOMA (CTCL) IN CLINICAL PRACTICE IN FRANCE, GERMANY ITALY, SPAIN AND THE UNITED KINGDOM

EHA Library, Tim Illidge, 266873

LYMPHOCYTE TO MONOCYTE RATIO (LMR) PREDICTS PROGRESSION-FREE SURVIVAL INDEPENDENTLY FROM FLIPI AND IS USEFUL IN IDENTIFYING PATIENTS WITH EARLY DISEASE PROGRESSION

EHA Library, Giuseppe Gritti, 266874

CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL-MZ): CLINICAL SIGNIFICANCE OF ABSOLUTE CLONAL B CELL COUNTS

EHA Library, Christina Kalpadakis, 266875

LONG-TERM FOLLOW-UP OF JCOG0406 STUDY: INTENSIVE IMMUNOCHEMOTHERAPY (R-HIGH CHOP/CHASER) FOLLOWED BY HIGH-DOSE CHEMOTHERAPY (LEED) WITH AUTO-PBSCT IN UNTREATED MANTLE CELL LYMPHOMA

EHA Library, Michinori Ogura, 266876

EFFICACY OF MOGAMULIZUMAB IN PREVIOUSLY TREATED PATIENTS WITH LESS ADVANCED MYCOSIS FUNGOIDES: RESULTS FROM THE MAVORIC STUDY

EHA Library, Pier Luigi Zinzani, 266877

CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS OF 33 PATIENTS WITH SEZARY SYNDROME AT MOFFITT CANCER CENTER: A SINGLE-INSTITUTION COHORT

EHA Library, Yumeng Zhang, 266878

POST HOC ANALYSIS OF THE AUGMENT PHASE III RANDOMIZED STUDY OF LENALIDOMIDE PLUS RITUXIMAB (R2) VS RITUXIMAB/PLACEBO IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA

EHA Library, Catherine Thieblemont, 266879

CONSOLIDATION THERAPY USING 90Y-IBRITUMOMAB TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRIZ2012)

EHA Library, Hideki Tsujimura, 266880

FRENCH IBRUTINIB OBSERVATIONAL STUDY (FIRE): REAL-WORLD STUDY OF IBRUTINIB TREATMENT FOR MANTLE CELL LYMPHOMA (MCL) IN FRANCE

EHA Library, Steven Le Gouill, 266881

IMPROVEMENTS IN OUTCOME OF MANTLE-CELL LYMPHOMA (MCL) ARE MOSTLY DUE TO ADVANCES IN INDUCTION THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) - A REAL-LIFE NON-INTERVENTIONAL STUDY OF KROHEM

EHA Library, Igor Aurer, 266882

CLINICAL ASPECTS, MORPHOLOGICAL ANALYSIS AND IMMUNOHISTOCHEMICAL CHARACTERISTICS OF PATIENTS WITH FOLLICULAR LYMPHOMA IN DUODENUM BIOPSY: CASES WITH RESTRICT DISEASE VERSUS ADVANCED PRESENTATION.

EHA Library, Guilherme Duffles, 266883

ISAVUCONAZOLE IN HEMATOLOGICAL PATIENTS: FINAL RESULTS OF A REAL-LIFE MULTICENTER SEIFEM (SORVEGLIANZA EPIDEMIOLOGICA DELLE INFEZIONI NELLE EMOPATIE) STUDY

EHA Library, Chiara Cattaneo, 266884

CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS

EHA Library, Daniela Clerici, 266885

AUTOIMMUNE NEUTROPENIA OF INFANCY- UNEXPECTED PREVALENCE OF PSEUDOMONAS SKIN INFECTIONS

EHA Library, Joanne Yacobovich, 266886

HIGH INCIDENCE OF CYTOMEGALOVIRUS (CMV) REACTIVATION IN HEMATOLOGICAL PATIENTS TREATED WITH BENDAMUSTINE BASED CHEMOTERAPY REGIMENS

EHA Library, MATTEO D'ADDONA, 266887

PREDICTORS, RATES AND COSTS ASSOCIATED WITH READMISSION FOR CLOSTRIDIUM DIFFICILE INFECTION WITHIN 90 DAYS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION: INSIGHT FROM THE NATIONWIDE READMISSION DATABASE

EHA Library, Eman M. Elsabbagh, 266888

A SURVEY OF PRACTICE RELATING TO THE PREVENTION AND TREATMENT OF INVASIVE FUNGAL INFECTIONS IN UK HAEMATOLOGY CENTRES

EHA Library, Nick Duncan, 266889

PREDICTIVE FACTORS FOR LINE-ASSOCIATED BLOODSTREAM INFECTIONS IN PATIENTS WITH HAEMATOLOGIC MALIGNANCIES: COMPARISON OF TUNNELLED CATHETERS AND PERIPHERALLY INSERTED CENTRAL CATHETERS

EHA Library, Daniel Farrugia, 266890

EPIDEMIOLOGY AND MANAGEMENT OF LATENT TUBERCULOSIS INFECTION IN ADULT PATIENTS WITH ACUTE LEUKEMIA OR APLASTIC ANEMIA: A RETROSPECTIVE MONOCENTER STUDY

EHA Library, Francesca Bettelli, 266891

INVASIVE ASPERGILLOSIS CAUSED BY 'RARE' PATHOGENS: CLINICAL REGISTRY DATA ANALYSIS

EHA Library, Nikolay Klimko, 266892

EPIDEMIOLOGY AND CLINICAL OUTCOME OF FUNGAL INFECTIONS OF THE CENTRAL NERVOUS SYSTEM IN ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS.

EHA Library, Anna CANDONI, 266893

EVALUATION OF THE IMMUNITY TO MEASLES, MUMPS AND RUBELLA IN ADULT PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Koji Kawamura, 266894

LACTATE CLEARANCE AS A SURVIVAL PREDICTOR IN PATIENTS WITH HEMATOLOGIC DISEASES WITH SEPTIC SHOCK

EHA Library, Iurii Osipov, 266895

A PRACTICAL UPDATE ON THE EPIDEMIOLOGY AND RISK FACTORS FOR THE EMERGENCE AND MORTALITY OF BLOODSTREAM INFECTIONS IN 3014 PATIENTS WITH HEMATOLOGICAL MALIGNANCY RECEIVING CHEMOTHERAPY

EHA Library, zhen Chen, 266896

FUNGAL INFECTIONS IN ACUTE MYELOID LEUKEMIA IN THE POSACONAZOLE ERA

EHA Library, Carolina Marini, 266897

EFFICACY OF ACTIVE SURVEILLANCE IN REDUCING MORTALITY DUE TO MULTIDRUG RESISTANT BACTERIA IN ACUTE LEUKEMIA

EHA Library, M Angeles Fernández-Rodríguez, 266898

INFECTIOUS COMPLICATIONS OF NIVOLUMAB THERAPY IN RELAPSED/REFRACTORY HODGKIN’S LYMPHOMA

EHA Library, Yuliya Rogacheva, 266899

CLINICAL IMPLICATIONS OF AZOLE-RESISTANT VERSUS AZOLE-SUSCEPTIBLE INVASIVE ASPERGILLOSIS IN HEMATOLOGICAL MALIGNANCY (CLARITY) - A MULTICENTER STUDY

EHA Library, Danila Seidel, 266900

GLOBAL GUIDELINE FOR THE DIAGNOSIS AND MANAGEMENT OF MUCORMYCOSIS: AN INITIATIVE OF THE ECMM IN COOPERATION WITH THE MSG ERC

EHA Library, Oliver Cornely, 266901

INVASIVE FUNGAL DISEASES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS WITH HODGKIN’S LYMPHOMA

EHA Library, Yuliya Rogacheva, 266902

INVASIVE YEAST INFECTIONS IN HEMATOLOGICAL PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Yuliya Rogacheva, 266903

INVASIVE ASPERGILLOSIS IN PATIENTS WITH B-CELL LYMPHOMA

EHA Library, Nikolay Klimko, 266904

SAFETY AND UTILIZATION OF MIDLINE CATHETERS VERSUS TUNNELED CENTRAL VENOUS CATHETERS IN THE MANAGEMENT OF ACUTE MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE.

EHA Library, Hélène Gardeney, 266905

THE ATYPICAL LYMPHOCYTE COUNT: A NOVEL PREDICTIVE FACTOR FOR SEVERE DENGUE INFECTION

EHA Library, Visula Abeysuriya, 266906

HEPARIN-ANALOGUE SEVUPARIN INHIBITS STREPTOCOCCUS-INDUCED VASCULAR HYPERPERMEABILITY THROUGH NEUTRALIZING NEUTROPHIL-DERIVED PROTEINS

EHA Library, Mats WAHLGREN, 266907

THE DEVELOPMENT OF IRON OVERLOAD SYNDROME IN PATIENTS WITH LOW-/INTERMEDIATE RISK MYELODYSPLASTIC SYNDROME

EHA Library, Tatiana Babaeva, 266908

LINK BETWEEN IRON AND TRYPTOPHAN METABOLISM OBSERVED IN INDIVIDUALS WITH IRON DEFICIENCY AND ANEMIA

EHA Library, Dietmar Enko, 266909

OSTEOGENESIS IMPERFECTA : A NEW UNRECOGNIZED ETIOLOGY FOR FUNCTIONAL IRON DEFICIENCY

EHA Library, Iman Ragab, 266910

MULTIFACTORIAL HEPCIDIN SUPPRESSION IN BETA-THALASSEMIA CARRIERS WITH IRON OVERLOAD

EHA Library, Fabiana Busti, 266911

IRON IN THE HUMAN HEARTS: DISTRIBUTION AND ASSOCIATION WITH R2* VALUES BY CMR

EHA Library, Antonella Meloni, 266912

ERYTROCYTAPHERESIS IN ACERULOPLASMINEMIA PREVENTS PROGRESSION OF CEREBRAL IRON ACCUMULATION AFTER CHELATOR-INDUCED NORMALIZATION OF IRON STORES

EHA Library, Michel van Gelder, 266913

EFFICACY AND SAFETY OF INTRAVENOUS IRON THERAPY IN CHILDREN: A KOREAN SINGLE CENTER STUDY

EHA Library, Nani Jung, 266914

TISSUE IRON DISTRIBUTION IN PATIENTS WITH LOW-RISK MDS

EHA Library, Regine Grosse, 266915

SOLUBLE TRANSFERRIN RECEPTOR AND ITS FERRITIN INDEX IN COMPARISON WITH BIOCHEMICAL AND HEMATOLOGICAL PARAMETERS FOR THE DIFFERENTIATION OF ANEMIA STATES AND CORRELATION WITH IV IRON RESPONSE

EHA Library, Nina Petkova, 266916

A NURSE LED IRON INFUSION CLINIC REDUCES POTENTIAL PATIENT HARM AND IMPROVES HOSPITAL EFFICIENCY

EHA Library, Laurie Newman, 266917

POTENT ANTI-TUMOR ACTIVITY OF DUOBODY®-CD3XCD20 IN PRECLINICAL MODELS IN VITRO AND IN VIVO

EHA Library, Ida H. Hiemstra, 266918

THE CD58-CD2 AXIS CONTROLS KILLING OF B CELLS BY CYTOTOXIC T CELLS

EHA Library, Anna KABANOVA, 266919

CHRONIC TCR STIMULATION PROMOTES PERIPHERAL T-CELL LYMPHOMAGENESIS AND INDUCES ADDICTION TO SYK AND NK RECEPTOR SIGNALING.

EHA Library, Sylvain Carras, 266920

FOLLICULAR HELPER T-CELLS FORM MUTUALLY SUPPORTIVE INTERACTIONS WITH FOLLICULAR LYMPHOMA B-CELLS THAT MAY SUPPORT TUMOUR GROWTH

EHA Library, Elizabeth PHILLIPS, 266921

CHARACTERIZATION OF ENDOGENOUS CXCR4 INHIBITORY PEPTIDES TO TARGET WALDENSTRÖM’S MACROGLOBULINEMIA

EHA Library, Lisa Marie Kaiser, 266922

JAB1/CSN5 STABILIZES PD-L1 PROTEIN AND CORRELATES WITH STAT3 ACTIVATION IN T-CELL LYMPHOMAS

EHA Library, George RASSIDAKIS, 266923